SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels shares plunged after its quarterly report paired a results beat with a sharply weaker next-quarter outlook, with PC softness and manufacturing constraints weighing on expectations; analyst downgrades added pressure. Traders are divided between viewing the selloff as an overreaction and buying the dip, or seeing the outlook and turnaround risks as reasons for further caution.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks sharp selloff despite an earnings beat, higher guidance and an announced forward stock split is driving discussion. Traders debate whether the drop reflects broad tech and memory-sector selling or concerns about slowing growth, a possible NAND pricing peak and profit-taking after a steep rally.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are under heavy pressure after its quarterly report paired strong results with a softer revenue outlook, weaker user growth, and declining Google search referrals; plans to test a logged-in-focused experience have added concerns about traffic and ad growth. Traders are split between viewing the selloff as an overreaction and fearing that search-driven traffic losses could undermine the growth story.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is falling with AI and semiconductor stocks as Amazon and Intel results sharpen concerns that heavy data-center spending may not deliver adequate returns; traders also point to reports that Nvidia is discussing credit guarantees for an Nscale facility tied to Anthropic, raising circular-financing worries. The debate pits fears of an AI-capex bubble against dip buyers who argue that Intels PC weakness does not reflect Nvidias AI demand.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is selling off amid weakness in major technology stocks, with Amazon and Intel results intensifying concerns about heavy AI spending, cash burn, and the returns on those investments. Traders are broadly bearish and debating whether the decline signals a deeper AI-led correction, while some see the selloff as an oversold buying opportunity.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp selloff in semiconductor and tech sharesespecially after Intels weak outlook and concerns about PC demandhas hammered SOXL, with traders also citing broader AI-trade worries and market weakness. The community is split between calling the decline an oversold buying opportunity and warning that leveraged losses and further downside could continue.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is caught in a broad technology and semiconductor selloff, with traders pointing to Intels weak outlook and concerns about AI spending and valuations rather than a clear AMD-specific development; the drop has sharpened focus on AMDs upcoming earnings. Views split between dip buyers who see Intels struggles as a potential opportunity for AMD and bears worried about valuation and further downside.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

A sharp semiconductor selloff, amplified by Intels weak outlook and softer PC demand, is weighing on SOXX. Traders debate whether the drop is a buying opportunityarguing AI-chip demand remains strongor a sign of a deeper correction amid concerns about AI valuations and spending.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is under pressure after DaVitas CFO said the company expects DefenCaths post-TDAPA reimbursement contribution to drop significantly after Q1 2027, stoking concerns about future adoption and revenue. Traders disagree on how broadly to interpret DaVitas preliminary, company-specific estimate, with some arguing the finalized CMS payment and its outlook do not establish an industry-wide reimbursement collapse.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp broad-market selloff is driving attention, with traders focused on tech weakness after Amazons and Intels results intensified concerns about AI spending and returns. Posts also cite Iran-related oil and geopolitical risks and midterm uncertainty, while some expect further declines and others see a buying opportunity or bounce.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ATHE The following paragraphs sums up their position.  Key words are &quot;continues to evaluate&quot;, &quot;ongoing discussions with a number of pharmaceutical companies&quot;, &quot;progressing&quot;, &quot;assistance of external advisor&quot;.  These are constructive statements being used.  They are not simply saying they are considering or looking into partnership opportunities but rather they continue to stay engaged in ongoing discussions which is constructive.  I think they prefer a partnership over dilution because CEO did mention in the October Fireside Chat that they are not supportive of dilution because of Management&#39;s &quot;angst&quot; towards issuing more shares.

Paul Alexander

Joey Ohiwerei

StockTwits Web

Alterity Therapeutics Ltd - ADR

 The following paragraphs sums up their position.  Key words are "continues to evaluate", "ongoing discussions with a number of pharmaceutical companies", "progressing", "assistance of external advisor".  These are constructive statements being used.  They are not simply saying they are considering or looking into partnership opportunities but rather they continue to stay engaged in ongoing discussions which is constructive.  I think they prefer a partnership over dilution because CEO did mention in the October Fireside Chat that they are not supportive of dilution because of Management's "angst" towards issuing more shares.

@GA09 While fear is definitely impacting my position, I have a gut feeling the bottom is and we&#39;re in for nice surprise.

 While fear is definitely impacting my position, I have a gut feeling the bottom is and we're in for nice surprise.

@Joeyohis I share the pain!!!!  Wasn&#39;t expecting this to go to $2.00!!!!! IMHO, going alone to a Phase 3 trial will be challenging vs partnering with a pharma company with an already establised infrastructure and networks and if the pharam company is looking to diversify their CNS portfolio (example JNJ whcih acquired ITCI for $15B) and having the experience of carrying out a Phase 3 trial and getting drugs approved by the FDA at a faster pace.  ATHE is aware that the longer they wait, the more harm to existing patients who need 434 for their treatment.  We should be hearing soon since they have been having &quot;ongoing discussions&quot; for almost 3 months (that I am aware of).  This could be the bottom and we wake up to nice surprise one morning on ATHE securing a lucrative partnership with pharma (the likes of AZN, NVS, JNJ, LLY, PFE, BMY, etc.).

 I share the pain!!!!  Wasn't expecting this to go to $2.00!!!!! IMHO, going alone to a Phase 3 trial will be challenging vs partnering with a pharma company with an already establised infrastructure and networks and if the pharam company is looking to diversify their CNS portfolio (example JNJ whcih acquired ITCI for $15B) and having the experience of carrying out a Phase 3 trial and getting drugs approved by the FDA at a faster pace.  ATHE is aware that the longer they wait, the more harm to existing patients who need 434 for their treatment.  We should be hearing soon since they have been having "ongoing discussions" for almost 3 months (that I am aware of).  This could be the bottom and we wake up to nice surprise one morning on ATHE securing a lucrative partnership with pharma (the likes of AZN, NVS, JNJ, LLY, PFE, BMY, etc.).